廣告

2020年3月26日 星期四

FDA approves US coronavirus treatments:抗瘧疾藥物「奎寧」;從康復患者的血漿中測出抗體,可以有效治療患者 How Blood from Coronavirus Survivors Might Save Lives




日前美國總統川普曾在記者會上公開表示,抗瘧疾藥物「奎寧」已獲得美國食品藥物管理局核准用於治療新冠病毒。不過,美國有一對夫妻,自行服用奎寧,疑似引發藥物過敏,一死一命危。
奎寧藥物副作用,再度受到各界關注。國內醫師表示,藥物過敏是機率問題,台灣每年使用奎寧超過上百萬顆,其實是相對安全的藥物。



Hospitals in New York City are gearing up to use the blood of people who have recovered from COVID-19 as a possible antidote for the disease.

FDA approves first US coronavirus treatment: Doctors across the US can now treat the sickest Americans with plasma from recovered patients

  • The FDA Tuesday cleared the way for doctors to use blood plasma from people who have recovered from coronavirus to treat critically ill patients
  • Blood plasma contains antibodies that people infected by the disease develop to fight the virus 
  • Giving this antibody-rich plasma to a sick patient helps to ramp up their immune response to the foreign infection
  • Plasma transfusion has been used for centuries as well as in China to treat COVID-19 patients, but is limited by the number of recovered people to donate
  • It comes a day after New York Governor Andrew Cuomo announced that state intended to begin treating this method in its sickest patients  
  • Coronavirus symptoms: what are they and should you see a doctor?


Most patients who recovered from the illness produced specific antibodies against the virus. They're now being asked to donate blood plasma to help treat others.
武漢肺炎目前還未有治療的疫苗或藥物,而中國國藥集團旗下公司發現,從康復患者的血漿中測出抗體,可以有效治療患者

沒有留言:

網誌存檔